CA2188529C - Cristal de derive de pyrrolidylthiocarbapeneme, preparation lyophilisee le contenant et son procede de production - Google Patents
Cristal de derive de pyrrolidylthiocarbapeneme, preparation lyophilisee le contenant et son procede de production Download PDFInfo
- Publication number
- CA2188529C CA2188529C CA002188529A CA2188529A CA2188529C CA 2188529 C CA2188529 C CA 2188529C CA 002188529 A CA002188529 A CA 002188529A CA 2188529 A CA2188529 A CA 2188529A CA 2188529 C CA2188529 C CA 2188529C
- Authority
- CA
- Canada
- Prior art keywords
- crystal
- aqueous solution
- process according
- frozen
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000013078 crystal Substances 0.000 title claims abstract description 128
- 238000002360 preparation method Methods 0.000 title claims abstract description 54
- 238000000034 method Methods 0.000 title claims abstract description 46
- 230000008569 process Effects 0.000 title claims abstract description 35
- XLJMOHKQRRPBDS-IENPIDJESA-N (5S)-4-pyrrolidin-1-ylsulfanyl-1-azabicyclo[3.2.0]hept-2-en-7-one Chemical class N1(CCCC1)SC1C=CN2[C@H]1CC2=O XLJMOHKQRRPBDS-IENPIDJESA-N 0.000 title description 6
- 239000007864 aqueous solution Substances 0.000 claims abstract description 45
- 239000000243 solution Substances 0.000 claims abstract description 37
- 238000001816 cooling Methods 0.000 claims abstract description 29
- 238000010792 warming Methods 0.000 claims abstract description 27
- 238000007710 freezing Methods 0.000 claims abstract description 17
- 230000008014 freezing Effects 0.000 claims abstract description 17
- 150000001875 compounds Chemical class 0.000 claims abstract description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 33
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 32
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 21
- 150000003839 salts Chemical class 0.000 claims description 18
- 239000011780 sodium chloride Substances 0.000 claims description 16
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 11
- 229930195725 Mannitol Natural products 0.000 claims description 11
- 239000000594 mannitol Substances 0.000 claims description 11
- 235000010355 mannitol Nutrition 0.000 claims description 11
- 238000000634 powder X-ray diffraction Methods 0.000 claims description 10
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 8
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 1
- 235000017550 sodium carbonate Nutrition 0.000 claims 1
- 235000011121 sodium hydroxide Nutrition 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 238000007792 addition Methods 0.000 description 45
- 238000002425 crystallisation Methods 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 230000008025 crystallization Effects 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 17
- 238000003860 storage Methods 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- 239000003002 pH adjusting agent Substances 0.000 description 10
- 239000003814 drug Substances 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 229910052708 sodium Inorganic materials 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- 238000001291 vacuum drying Methods 0.000 description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- 238000002441 X-ray diffraction Methods 0.000 description 7
- 239000002585 base Substances 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 239000003960 organic solvent Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- -1 alkali metal halide salts Chemical class 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 3
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical class N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 238000012792 lyophilization process Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229910016523 CuKa Inorganic materials 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical group C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229910001508 alkali metal halide Inorganic materials 0.000 description 1
- 229910052936 alkali metal sulfate Inorganic materials 0.000 description 1
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000019628 coolness Nutrition 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- AVAACINZEOAHHE-VFZPANTDSA-N doripenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](CNS(N)(=O)=O)C1 AVAACINZEOAHHE-VFZPANTDSA-N 0.000 description 1
- 230000005496 eutectics Effects 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Cristal d'acide (1R, 5S, 6S)-6-[(1R)-1-hydroxyéthyl]-2-[(3S, 5S)-5-sulfamoylaminométhyl-1-pyrrolidin-3-yl]thio-1-méthyl-1-carba-2-penem-3-carboxylique représenté par la formule (I). Le procédé de production d'une préparation lyophilisée contenant les cristaux comprend l'étape de congélation d'une solution aqueuse du composé précité par refroidissement à -20 DEG C ou moins, l'étape de réchauffement de la solution congelée entre 0 et -10 DEG C, et l'étape de refroidissement et de réchauffement de la solution au moins deux fois dans la plage de températures comprise entre 0 et -10 DEG C.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9353794 | 1994-05-02 | ||
| JP6-93537 | 1994-05-02 | ||
| JP10855494 | 1994-05-23 | ||
| JP6-108554 | 1994-05-23 | ||
| PCT/JP1995/000858 WO1995029913A1 (fr) | 1994-05-02 | 1995-04-28 | Cristal de derive de pyrrolidylthiocarbapeneme, preparation lyophilisee le contenant et son procede de production |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2188529A1 CA2188529A1 (fr) | 1995-11-09 |
| CA2188529C true CA2188529C (fr) | 2005-12-06 |
Family
ID=35519669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002188529A Expired - Lifetime CA2188529C (fr) | 1994-05-02 | 1995-04-28 | Cristal de derive de pyrrolidylthiocarbapeneme, preparation lyophilisee le contenant et son procede de production |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2188529C (fr) |
-
1995
- 1995-04-28 CA CA002188529A patent/CA2188529C/fr not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2188529A1 (fr) | 1995-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0758651B1 (fr) | Cristal de derive de pyrrolidylthiocarbapeneme, preparation lyophilisee le contenant et son procede de production | |
| US10294224B2 (en) | Lyophilized composition of a diazabicyclooctane compound and process of producing the same | |
| US4775751A (en) | Process for cephalexin hydrochloride alcoholates | |
| RU2607083C2 (ru) | Кристалл циклопептида высокой чистоты, а также способ его получения и его применение | |
| CA2188529C (fr) | Cristal de derive de pyrrolidylthiocarbapeneme, preparation lyophilisee le contenant et son procede de production | |
| WO2003018578A1 (fr) | Methode de production de la forme beta anhydre cristalline de l'acide ((z)-2-[[[(2-amino-4-thiazolyl)[[$i(trans)-(2s,3s)-2-methyl-4-oxo-1-sulfo-3-azetidinyl]carbamoyl]methylene]amino]oxy]-2-methylpropionique (aztreonam) | |
| KR20030092117A (ko) | β-락탐 화합물의 무수 결정 및 그의 제조 방법 | |
| JP2843444B2 (ja) | ピロリジルチオカルバペネム誘導体の結晶，該結晶を含む凍結乾燥製剤，およびその製造方法 | |
| US4754030A (en) | Cefbuperazone crystalline triethylamine salt | |
| US4104470A (en) | Crystallization process for cefazolin sodium | |
| JPWO1995029913A1 (ja) | ピロリジルチオカルバペネム誘導体の結晶、該結晶を含む凍結乾燥製剤、およびその製造方法 | |
| JP2003503506A (ja) | ４”−置換−９−デオキソ−９ａ−アザ−９ａ−ホモエリスロマイシン誘導体の二リン酸塩及びその医薬組成物 | |
| EP0018811B1 (fr) | Epimère cristallin antibiotique, sa préparation et composition pharmaceutique le contenant | |
| JP7782021B2 (ja) | エルタペネムナトリウムの新規な結晶形及びその製造方法 | |
| KR840000036B1 (ko) | 옥사-β-락탐 2산 화합물의 D-세스퀴나트륨염의 제조방법 | |
| US4276421A (en) | Cyano-guanidine geometrical isomers | |
| US4668782A (en) | Anhydrous crystalline or crystalline hemihydrate monohydrate or trihydrate of cephalosporin derivative | |
| KR0169534B1 (ko) | 고밀도의 고결정성 세포페라존 나트륨염 및 그의 제조방법 | |
| JPH0552836B2 (fr) | ||
| EP0381915B1 (fr) | Procédé de préparation de sels de métaux alcalins de dérivés de l'acide 7-aminocéphalo-sporanique. | |
| WO1993015076A1 (fr) | Procede de separation d'acides foliniques | |
| KR20090057843A (ko) | (1Ｒ,5Ｒ,6Ｓ)-ｐ-니트로벤질-2-(디페닐포스포릴옥시)-6-[(Ｒ)-1-히드록시에틸]-1-메틸-카바페넴-3-카복실레이트의신규한 결정형 및 그의 제조방법 | |
| JPH0665254A (ja) | セフォラニド誘導体 | |
| EP2947069A1 (fr) | Sulfate de 5-hydroxy-1h-imidazole-4-carboxamide | |
| EP1604976A1 (fr) | Dérivé de Nimésulide, procédé de préparation et composition pharmaceutique le contenant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20150428 |
|
| MKEX | Expiry |
Effective date: 20150428 |